BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wakabayashi H, Nishiyama Y, Otani T, Sano T, Yachida S, Okano K, Izuishi K, Suzuki Y. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol 2008; 14(1): 64-69 [PMID: 18176963 DOI: 10.3748/wjg.14.64]
URL: https://www.wjgnet.com/1007-9327/full/v14/i1/64.htm
Number Citing Articles
1
Gaia Grassetto, Domenico Rubello. Role of FDG-PET/CT in Diagnosis, Staging, Response to Treatment, and Prognosis of Pancreatic CancerAmerican Journal of Clinical Oncology 2011; 34(2): 111 doi: 10.1097/COC.0b013e3181d275a0
2
Sang Mi Lee, Tae-Sung Kim, Jeong Won Lee, Seok-Ki Kim, Sang-Jae Park, Sung-Sik Han. Improved Prognostic Value of Standardized Uptake Value Corrected for Blood Glucose Level in Pancreatic Cancer Using F-18 FDG PETClinical Nuclear Medicine 2011; 36(5): 331 doi: 10.1097/RLU.0b013e31820a9eea
3
J. R. Delpero. Post’U FMC-HGE2011; : 185 doi: 10.1007/978-2-8178-0237-4_25
4
Woohyun Jung, Jin-Young Jang, Mee Joo Kang, Ye Rim Chang, Yong Chan Shin, Jihoon Chang, Sun-Whe Kim. The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography–computed tomography (PET–CT) in follow-up of curatively resected pancreatic cancer patientsHPB 2016; 18(1): 57 doi: 10.1016/j.hpb.2015.06.001
5
Sung Jun Ahn, Mi-Suk Park, Jong Doo Lee, Won Jun Kang. Correlation between 18F-fluorodeoxyglucose positron emission tomography and pathologic differentiation in pancreatic cancerAnnals of Nuclear Medicine 2014; 28(5): 430 doi: 10.1007/s12149-014-0833-x
6
Randy Yeh, Jonathan Steinman, Lyndon Luk, Michael D. Kluger, Elizabeth M. Hecht. Imaging of pancreatic cancer: what the surgeon wants to knowClinical Imaging 2017; 42: 203 doi: 10.1016/j.clinimag.2016.10.002
7
Ho Seok I, Seong-Jang Kim, In Joo Kim, Keunyoung Kim. Predictive Value of Metabolic Tumor Volume Measured by 18F-FDG PET for Regional Lymph Node Status in Patients With Esophageal CancerClinical Nuclear Medicine 2012; 37(5): 442 doi: 10.1097/RLU.0b013e318238f703
8
Shun Zhang, Yi-Ming Wang, Chuan-Dong Sun, Yun Lu, Li-Qun Wu. Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinomaWorld Journal of Gastroenterology 2008; 14(23): 3750-3753 doi: 10.3748/wjg.14.3750
9
Jin-Ping Lai, Yong Yue, Wei Zhang, Yihua Zhou, David Frishberg, Laith H. Jamil, James M. Mirocha, Maha Guindi, Bonnie Balzer, Shikha Bose, Dengfeng Cao, Simon Lo, Xuemo Fan, Joanne K. Rutgers. Comparison of endoscopic ultrasound guided fine needle aspiration and PET/CT in preoperative diagnosis of pancreatic adenocarcinomaPancreatology 2017; 17(4): 617 doi: 10.1016/j.pan.2017.04.008
10
Paul F. Laeseke, Ru Chen, R. Brooke Jeffrey, Teresa A. Brentnall, Jürgen K. Willmann. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and SolutionsRadiology 2015; 277(3): 644 doi: 10.1148/radiol.2015141020
11
Jian Zhang, Chang-Jing Zuo, Ning-Yang Jia, Jian-Hua Wang, Sheng-Ping Hu, Zhong-Fei Yu, Yuan Zheng, An-Yu Zhang, Xiao-Yuan Feng. Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancerWorld Journal of Gastroenterology 2015; 21(10): 2988-2996 doi: 10.3748/wjg.v21.i10.2988
12
Todd M. Blodgett, Sanjay Paidisetty, Paul Shreve. Clinical PET-CT in Radiology2011; : 407 doi: 10.1007/978-0-387-48902-5_31
13
P.M. Vineeth Kumar, G.R. Verma, B.R. Mittal, Kanhaiyalal Agrawal, Rahul Gupta, Rakesh Kochhar, Virendra Singh, Lileshwar Kaman, Rajinder Singh. FLT PET/CT Is Better Than FDG PET/CT in Differentiating Benign From Malignant Pancreatobiliary LesionsClinical Nuclear Medicine 2016; 41(5): e244 doi: 10.1097/RLU.0000000000001163
14
Xiao-Yi Wang, Feng Yang, Chen Jin, De-Liang Fu. Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancerWorld Journal of Gastroenterology 2014; 20(42): 15580-15589 doi: 10.3748/wjg.v20.i42.15580
15
Ippei Matsumoto, Sachiyo Shirakawa, Makoto Shinzeki, Sadaki Asari, Tadahiro Goto, Tetsuo Ajiki, Takumi Fukumoto, Kazuhiko Kitajima, Yonson Ku. 18-Fluorodeoxyglucose Positron Emission Tomography Does Not Aid in Diagnosis of Pancreatic Ductal AdenocarcinomaClinical Gastroenterology and Hepatology 2013; 11(6): 712 doi: 10.1016/j.cgh.2012.12.033
16
Aparna Balachandran, Priya Bhosale, Chuslip Charnsangavej. Pancreatic Cancer2010; : 703 doi: 10.1007/978-0-387-77498-5_29
17
Keiichi Okano, Hironobu Suto, Minoru Oshima, Yasuhisa Ando, Mina Nagao, Hideki Kamada, Hideki Kobara, Tsutomu Masaki, Hiroyuki Okuyama, Yoshihiro Okita, Akihito Tsuji, Yasuyuki Suzuki. 18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancerJapanese Journal of Clinical Oncology 2018; 48(5): 434 doi: 10.1093/jjco/hyy033
18
Daniella F. Pinho, Rathan M. Subramaniam. PET–Computed Tomography and Precision Medicine in Pancreatic Adenocarcinoma and Pancreatic Neuroendocrine TumorsPET Clinics 2017; 12(4): 407 doi: 10.1016/j.cpet.2017.05.003
19
Sampath Santhosh, Bhagwant Rai Mittal, Surinder Singh Rana, Radhika Srinivasan, Anish Bhattacharya, Ashim Das, Deepak Bhasin. Metabolic signatures of malignant and non-malignant mass-forming lesions in the periampulla and pancreas in FDG PET/CT scan: an atlas with pathologic correlationAbdominal Imaging 2015; 40(5): 1285 doi: 10.1007/s00261-014-0266-y
20
Anna Maria De Gaetano, Vittoria Rufini, Paola Castaldi, Anna Maria Gatto, Laura Filograna, Alessandro Giordano, Lorenzo Bonomo. Clinical applications of 18F-FDG PET in the management of hepatobiliary and pancreatic tumorsAbdominal Imaging 2012; 37(6): 983 doi: 10.1007/s00261-012-9845-y
21
K. Tabata, A. Nishie, Y. Shimomura, T. Isoda, Y. Kitamura, K. Nakata, Y. Yamada, Y. Oda, K. Ishigami, S. Baba. Prediction of pathological response to preoperative chemotherapy for pancreatic ductal adenocarcinoma using 2-[18F]-fluoro-2-deoxy-d-glucose positron-emission tomographyClinical Radiology 2022; 77(6): 436 doi: 10.1016/j.crad.2022.03.001
22
C. Pery, G. Meurette, C. Ansquer, E. Frampas, N. Regenet. Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesionsGastroentérologie Clinique et Biologique 2010; 34(8-9): 465 doi: 10.1016/j.gcb.2009.04.014
23
Saila P. Kauhanen, Gaber Komar, Marko P. Seppänen, Kirsti I. Dean, Heikki R. Minn, Sami A. Kajander, Irina Rinta-Kiikka, Kalle Alanen, Ronald J. Borra, Pauli A. Puolakkainen, Pirjo Nuutila, Jari T. Ovaska. A Prospective Diagnostic Accuracy Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Diagnosis and Staging of Pancreatic CancerAnnals of Surgery 2009; 250(6): 957 doi: 10.1097/SLA.0b013e3181b2fafa
24
Farzad Alemi, Adnan Alseidi, W. Scott Helton, Flavio G. Rocha. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinomaCurrent Problems in Surgery 2015; 52(9): 362 doi: 10.1067/j.cpsurg.2015.07.003
25
Domenico Tamburrino, Deniece Riviere, Mohammad Yaghoobi, Brian R Davidson, Kurinchi Selvan Gurusamy. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerCochrane Database of Systematic Reviews 2016; 2016(9) doi: 10.1002/14651858.CD011515.pub2
26
Francisco Sánchez-Bueno, Rocío García-Pérez, María Antonia Claver Valderas, Jesús de la Peña Moral, Laura Frutos Esteban, Eduardo Ortiz Ruiz, Matilde Fuster Quiñonero, Pascual Parrilla Paricio. Utilidad de la 18-fluorodeoxiglucosa en la tomografía por emisión de positrones-tomografía computarizada (PET-TC) preoperatoria en el diagnóstico precoz del cáncer de páncreas exocrino: estudio en 139 casos resecadosCirugía Española 2016; 94(9): 511 doi: 10.1016/j.ciresp.2016.07.007
27
Lawrence MJ Best, Vishal Rawji, Stephen P Pereira, Brian R Davidson, Kurinchi Selvan Gurusamy. Imaging modalities for characterising focal pancreatic lesionsCochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD010213.pub2
28
Seong-Jang Kim, In-Ju Kim, Kuen Tak Suh, Yong-Ki Kim, Jung Sub Lee. Prediction of Residual Disease of Spine Infection Using F-18 FDG PET/CTSpine 2009; 34(22): 2424 doi: 10.1097/BRS.0b013e3181b1fd33
29
YoungSeok Seo, Mi-Sook Kim, SungYul Yoo, ChulKoo Cho, KwangMo Yang, HyungJun Yoo, ChulWon Choi, DongHan Lee, Jin Kim, Min Suk Kim, HyeJin Kang, YoungHan Kim. Stereotactic Body Radiation Therapy Boost in Locally Advanced Pancreatic CancerInternational Journal of Radiation Oncology*Biology*Physics 2009; 75(5): 1456 doi: 10.1016/j.ijrobp.2009.01.042
30
A.P. Rijkers, R. Valkema, H.J. Duivenvoorden, C.H.J. van Eijck. Usefulness of F-18-fluorodeoxyglucose positron emission tomography to confirm suspected pancreatic cancer: A meta-analysisEuropean Journal of Surgical Oncology (EJSO) 2014; 40(7): 794 doi: 10.1016/j.ejso.2014.03.016
31
Peter Einersen, Irene Epelboym, Megan D. Winner, David Leung, John A. Chabot, John D. Allendorf. Positron Emission Tomography (PET) has Limited Utility in the Staging of Pancreatic AdenocarcinomaJournal of Gastrointestinal Surgery 2014; 18(8): 1441 doi: 10.1007/s11605-014-2529-x
32
A.-C. Lefebvre, J. Maurel, S. Boutreux, V. Bouvier, J.-M. Reimund, G. Launoy, D. Arsene. Pancreatic cancer: Incidence, treatment and survival trends – 1175 cases in Calvados (France) from 1978 to 2002Gastroentérologie Clinique et Biologique 2009; 33(10-11): 1045 doi: 10.1016/j.gcb.2009.04.011
33
Makoto Sakane, Mitsuaki Tatsumi, Masatoshi Hori, Hiromitsu Onishi, Takahiro Tsuboyama, Atsushi Nakamoto, Takashi Ota, Hidetoshi Eguchi, Kenichi Wakasa, Jun Hatazawa, Noriyuki Tomiyama. Volumetric parameters of 2-deoxy-2-[18F]fluoro- d -glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinomaEuropean Journal of Radiology 2017; 94: 64 doi: 10.1016/j.ejrad.2017.05.021
34
Nikhil Gupta, Raghav Yelamanchi. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and managementWorld Journal of Gastroenterology 2021; 27(23): 3158-3181 doi: 10.3748/wjg.v27.i23.3158
35
Bo Hyun Kim, In Joo Kim, Sang Soo Kim, Seong-Jang Kim, Chang Hun Lee, Yong-Ki Kim. Relationship Between Biological Marker Expression and Fluorine-18 Fluorodeoxyglucose Uptake in Incidentally Detected Thyroid CancerCancer Biotherapy and Radiopharmaceuticals 2010; 25(3): 309 doi: 10.1089/cbr.2009.0636
36
Mingxing Wang, Yunyun Xu, Min Yang, Dingyi Jiang, Yunwang Chen, Jiahong Jiang, Zheling Chen, Liu Yang, Dongsheng Huang. Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature ReviewFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.579239
37
Sampath Santhosh, Bhagwant Rai Mittal, Deepak Bhasin, Radhika Srinivasan, Surinder Rana, Ashim Das, Ritambhra Nada, Anish Bhattacharya, Rajesh Gupta, Rakesh Kapoor. Role of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: Experience from tropicsJournal of Gastroenterology and Hepatology 2013; 28(2): 255 doi: 10.1111/jgh.12068
38
Majid Assadi. Clinical Nuclear Medicine2020; : 597 doi: 10.1007/978-3-030-39457-8_19
39
Kazuhiro Kitajima, Koji Murakami, Erena Yamasaki, Yasushi Kaji, Mitsugi Shimoda, Keiichi Kubota, Narufumi Suganuma, Kazuro Sugimura. Performance of Integrated FDG-PET/Contrast-enhanced CT in the Diagnosis of Recurrent Pancreatic Cancer: Comparison with Integrated FDG-PET/Non-contrast-enhanced CT and Enhanced CTMolecular Imaging and Biology 2010; 12(4): 452 doi: 10.1007/s11307-009-0271-7
40
C. Buffet. Cancer du pancréas exocrine : clinique, bilan diagnostique et préthérapeutiqueEMC - Hépatologie 2009; 4(2): 1 doi: 10.1016/S1155-1976(09)48138-5
41
Man Soo Yun, Seong-Jang Kim, Kyoungjune Pak, Chang Hun Lee. Additional Prognostic Value of SUV<sub>max</sub> Measured by F-18 FDG PET/CT over Biological Marker Expressions in Surgically Resected Cervical Cancer PatientsOncology Research and Treatment 2015; 38(9): 413 doi: 10.1159/000438959
42
Ali Zakaria, Bayan Al-Share, Jason B. Klapman, Aamir Dam. The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic CancerCancers 2022; 14(6): 1373 doi: 10.3390/cancers14061373
43
Francisco Sánchez-Bueno, Rocío García-Pérez, María Antonia Claver Valderas, Jesús de la Peña Moral, Laura Frutos Esteban, Eduardo Ortiz Ruiz, Matilde Fuster Quiñonero, Pascual Parrilla Paricio. Utility of 18 Fludeoxyglucose in Preoperative Positon-Emission Tomography-Computed Tomography (PET-CT) in the Early Diagnosis of Exocrine Pancreatic Cancer: A Study of 139 Resected CasesCirugía Española (English Edition) 2016; 94(9): 511 doi: 10.1016/j.cireng.2016.11.006
44
Cosimo Sperti, Claudio Pasquali, Sergio Bissoli, Franca Chierichetti, Guido Liessi, Sergio Pedrazzoli. Tumor Relapse after Pancreatic Cancer Resection is Detected Earlier by 18-FDG PET than by CTJournal of Gastrointestinal Surgery 2010; 14(1): 131 doi: 10.1007/s11605-009-1010-8
45
Seong-Jang Kim, Yong-Ki Kim, In Joo Kim, Young Dae Kim, Min Ki Lee. Limited Predictive Value of Dual-Time-Point F-18 FDG PET/CT for Evaluation of Pathologic N1 Status in NSCLC PatientsClinical Nuclear Medicine 2011; 36(6): 434 doi: 10.1097/RLU.0b013e31820adef8
46
Sang I. Park, Dong S. Suh, Seong-Jang Kim, Kyung U. Choi, Man-Soo Yoon. Correlation between Biological Marker Expression and <sup>18</sup>F-Fluorodeoxyglucose Uptake in Cervical Cancer Measured by Positron Emission TomographyOncology Research and Treatment 2013; 36(4): 169 doi: 10.1159/000349944
47
Yizhen Pang, Long Zhao, Qihang Shang, Tinghua Meng, Liang Zhao, Liuxing Feng, Shuangjia Wang, Ping Guo, Xiurong Wu, Qin Lin, Hua Wu, Weipeng Huang, Long Sun, Haojun Chen. Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancerEuropean Journal of Nuclear Medicine and Molecular Imaging 2022; 49(4): 1322 doi: 10.1007/s00259-021-05576-w
48
L. Wang, P. Dong, W.G. Wang, B.L. Tian. Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysisInternational Journal of Surgery 2017; 46: 119 doi: 10.1016/j.ijsu.2017.09.003
49
Bo Hyun Kim, Min A. Na, In Joo Kim, Seong-Jang Kim, Yong-Ki Kim. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluationAnnals of Nuclear Medicine 2010; 24(10): 721 doi: 10.1007/s12149-010-0414-6
50
Kojun Okamoto, Isamu Koyama, Mitsuo Miyazawa, Yasuko Toshimitsu, Masayasu Aikawa, Katsuya Okada, Etsuko Imabayashi, Hiroshi Matsuda. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resectionInternational Journal of Clinical Oncology 2011; 16(1): 39 doi: 10.1007/s10147-010-0124-z
51
Seong-Jang Kim, Bo Hyun Kim, Yun Kyung Jeon, Sang Soo Kim, In Joo Kim. Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodulesAnnals of Nuclear Medicine 2011; 25(5): 347 doi: 10.1007/s12149-011-0468-0
52
Randy Yeh, Laurent Dercle, Ishan Garg, Zhen Jane Wang, David M. Hough, Ajit H. Goenka. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal AdenocarcinomaAbdominal Radiology 2018; 43(2): 415 doi: 10.1007/s00261-017-1374-2
53
Lujaien A Kadhim, Avani S Dholakia, Joseph M Herman, Richard L Wahl, Muhammad A Chaudhry. The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinomaJournal of Radiation Oncology 2013; 2(4): 341 doi: 10.1007/s13566-013-0130-7
54
Hye Jin Choi, Chang Moo Kang, Woo Jung Lee, Si Young Song, Arthur Cho, Mijin Yun, Jong Doo Lee, Joo Hang Kim, Jae-Hoon Lee. Prognostic Value of18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Resectable Pancreatic CancerYonsei Medical Journal 2013; 54(6): 1377 doi: 10.3349/ymj.2013.54.6.1377